Astrana Health, Inc. (ASTH) News
Follow Astrana Health, Inc. (ASTH) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 12 public stories across 7 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Astrana Health Reports Q3 Revenue Growth, Narrows 2026 Guidance
Astrana Health reported third-quarter 2026 revenue of $1.02 billion, up 7% year over year, and adjusted EBITDA of $77.2 million, up 13%. It narrowed its 2026 guidance ranges while maintaining their original midpoints.
EQUITY | Nov 09, 2026, 02:03 PM UTC
M
Astrana Health Reports Quarterly Results for Period Ended September 30
LSEG’s machine-generated earnings summary covers Astrana Health’s quarter ended September 30.
EQUITY | Nov 05, 2026, 11:28 PM UTC
M
Astrana Health Q3 Adjusted EPS Beats Estimates, Revenue Meets
EQUITY | Nov 05, 2026, 09:46 PM UTC
M
Astrana Health Reports Third-Quarter 2026 Results
Astrana Health reported its third-quarter 2026 results. The supplied body also says the company will host a conference call on November 5, 2026, at 2:30 p.m. PT/5:30 p.m. ET.
EQUITY | Nov 05, 2026, 09:06 PM UTC
M
Astrana Health schedules Q3 2026 results release call
EQUITY | Oct 09, 2026, 08:05 PM UTC
L
Why Astrana Health (ASTH) Shares Are Trading Lower Today
What Happened? Shares of healthcare services company Astrana Healthfell 5.5% in the afternoon session after the company disclosed a "material" cybersecurity incident and data breach at its subsidiary, Astrana Health Mana
EQUITY | Sep 23, 2026, 06:04 PM UTC
H
Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $4.004B Est
Astrana Health (NASDAQ: ASTH ) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.800 billion-$4.100 billion vs $4.004 billion estimate.
LIVE | Sep 23, 2026, 01:34 PM UTC
L
Astrana Health Detects Unusual Activity In Subsidiary Environment - SEC Filing
Astrana Health, Inc. NASDAQ:ASTH
REGULATION | Sep 23, 2026, 12:08 PM UTC
L
OUR NEW SHORT: $ASTH We are short Astrana Health, a value-based care company that has grown rapidly through acquisitions and increasingly complex risk-bearing arrangements. -- GLASSHOUSE RESEARCH
OUR NEW SHORT: $ASTH We are short Astrana Health, a value-based care company that has grown rapidly through acquisitions and increasingly complex risk-bearing arrangements. -- GLASSHOUSE RESEARCH
NEWS | Sep 17, 2026, 01:58 PM UTC
L
Astrana Health Price Target Announced at $53.00/Share by Oppenheimer
Ratings actions from Benzinga
NEWS | Sep 15, 2026, 01:57 PM UTC
H
Astrana Health updates corporate presentation, reiterates FY2026 guidance and $267.5M adj. EBITDA midpoint
Astrana Health updated its corporate presentation highlighting platform scale, FY2026 guidance and a $267.5M adjusted EBITDA midpoint.Key Highlights:Original SEC Filing: Astrana Health, Inc. [ ASTH ] - 8-K - Sep. 15, 202
EARNINGS | Sep 15, 2026, 12:55 PM UTC
L
Truist Securities Maintains Buy on Astrana Health, Raises Price Target to $55
Truist Securities analyst Jailendra Singh maintains Astrana Health (NASDAQ: ASTH ) with a Buy and raises the price target from $47 to $55.
EQUITY | Aug 11, 2026, 05:31 PM UTC
L
Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $4.001B Est
Astrana Health (NASDAQ: ASTH ) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.800 billion-$4.100 billion vs $4.001 billion estimate.
EARNINGS | Aug 06, 2026, 08:26 PM UTC